| Model Number |
TARP-27 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Anemia (1706); Hemolysis (1886)
|
| Date of Event |
03/25/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2026, a 27mm tailor flexible annuloplasty ring was implanted in the patient.Postoperatively, the patient had persistent hematuria and hemoglobin (hb) remained low after blood transfusion.An unexplained hemolysis occurred.A reoperation was performed on (b)(6) 2026, the ring got explanted and a new 27mm sjm masters series mechanical heart valve was implanted.The procedure was finished successfully without patient consequence.The patient remained stable throughout the procedure and is currently stable.
|
| |
|
Event or Problem Description
|
|
It was reported that on (b)(6) 2026, a 27mm tailor flexible annuloplasty ring was implanted in the patient.Postoperatively, the patient had persistent hematuria and hemoglobin (hb) remained low after blood transfusion.An unexplained hemolysis occurred.A reoperation was performed on (b)(6) 2026, the ring got explanted and a new 27mm sjm masters series mechanical heart valve was implanted.The procedure was finished successfully without patient consequence.The patient remained stable throughout the procedure and is currently stable.
|
| |
|
Additional Manufacturer Narrative
|
|
An event of persistent hematuria, low hemoglobin after blood transfusion and hemolysis was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was also reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported patient effects could not be conclusively determined.The reported medical intervention included blood transfusion to address the patient¿s condition.Surgical intervention involved a reoperation to explant the device.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|
| |
|
Search Alerts/Recalls
|